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Synaptic plasticity processes, which underlie learning and memory formation, require RNA to be translated local to synapses. The
synaptic tagging hypothesis has previously been proposed to explain how mRNAs are available at specific activated synapses.
However how RNA is regulated, and which transcripts are silenced or processed as part of the tagging process is still unknown.
Modification of RNA by N6-methyladenosine (m6A/m) influences the cellular fate of mRNA. Here, by advanced microscopy, we
showed that m6A demethylation by the eraser protein ALKBH5 occurs at active synaptic ribosomes and at synapses during short
term plasticity. We demonstrated that at activated glutamatergic post-synaptic sites, both the YTHDF1 and YTHDF3 reader and the
ALKBH5 eraser proteins increase in co-localisation to m6A-modified RNAs; but only the readers showed high co-localisation to
modified RNAs during late-stage plasticity. The YTHDF1 and YTHFDF3 readers also exhibited differential roles during synaptic
maturation suggesting that temporal and subcellular abundance may determine specific function. m6A-sequencing of human
parahippocampus brain tissue revealed distinct white and grey matter m6A methylome profiles indicating that cellular context is a
fundamental factor dictating regulated pathways. However, in both neuronal and glial cell-rich tissue, m6A effector proteins are
themselves modified and m6A epitranscriptional and posttranslational modification processes coregulate protein cascades. We
hypothesise that the availability m6A effector protein machinery in conjunction with RNA modification, may be important in the
formation of condensed synaptic nanodomain assemblies through liquid-liquid phase separation. Our findings support that m6A
demethylation by ALKBH5 is an intrinsic component of the synaptic tagging hypothesis and a molecular switch which leads to
alterations in the RNA methylome, synaptic dysfunction and potentially reversible disease states.
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INTRODUCTION
In eukaryotes, N6-methyladenosine (m6A) and the cap-adjacent
N6,2′‐O‐dimethyladenosine (m6Am), are highly abundant and
reversible mRNA modifications [1, 2]. m6A/m6Am modification is
regulated by effector proteins (writers, erasers and readers) which
orchestrate the transfer of methyl groups to and from adenosines
located internally or at the first transcribed position. Demethylase
eraser effector proteins remove m6A modifications and include
FTO and ALKBH5. Whilst the best characterised m6A-binding
proteins (readers), which recognise specific chemical modifica-
tions and direct binding events [3, 4], belong to the YTH domain
family of proteins [5–7]. Among them, the cytoplasmic YTHDF1,
YTHDF2 and YTHDF3 proteins have similar sequence identity and
binding affinities toward preferred RNA motifs [8, 9] and recent
studies support dosage dependent redundancy in their function
to regulate m6A dependent mRNA stability and translation [10–
12]. The mechanisms which govern this redundancy in a spatio-
temporal manner, and hence define the exact role of individual
YTHDF reader and eraser proteins in subcellular structures, is still
largely unknown.
Synaptic plasticity is widely accepted as the main neural basis of
learning and memory. Plasticity processes involve changes in
synaptic strength which require mRNA transcribed in the nucleus
as well as local translation of mRNA at dendritic sites [13]. Activity-
dependent plasticity processes occur in two phases, with an early,
short term, encoding phase (E-LTP) and a late phase occurring >4
h later (L-LTP) [14]. New protein synthesis, whether initiated
through activity-dependent transcription in the nucleus or
translation of pre-existing ‘stalled’ transcripts on dendritic ribo-
somes, contributes to these phases [13, 15]. The synaptic tagging
and capture hypothesis (STC) has been proposed to explain how
mRNAs are localised to, and available at, specific activated
synapses [16–18]. Although the STC model was originally
conceptualised as a cellular model of memory formation and
established by examining LTP in hippocampal tissue, the model is
relevant to other forms of plasticity and cognition [19–22].
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However, what constitutes the ‘synaptic tag’ remains unclear, and
it may include processes that regulate RNA stability, RNA
degradation and protein translation.
We hypothesise that m6A methylation is integral to a ‘synaptic
tagging and capture’ mechanism. Supporting this, knockout of the
reader, YTHDF1 in mice, results in impaired synaptic transmission and
learning and memory deficits and knockdown of YTHDF1 in mouse
cultured neurons results in abnormal spine morphology and impaired
synaptic transmission [23, 24]. To test our hypothesis, and using
advanced microscopy, we directly investigated the spatio-temporal
relationships between m6A-modified RNAs, and the YTHDF1 and
YTHDF3 readers and the demethylase ALKBH5 within synaptic
subdomains. We examined changes induced by NMDA-mediated
early and late phase plasticity stages, and at actively translating
synaptic ribosomes, as well as during the periods of synaptogenesis
and synaptic maturation in co-cultures of differentiating neurons,
astrocytes and oligodendrocytes. Furthermore, by m6A mapping of
grey and white matter from the human parahippocampus and late
stage foetal brain, we characterised m6A regulated processes and
m6A methylome characteristics in neuronal and glial cell-rich
hippocampal tissue and during late-stage brain development.
MATERIALS AND METHODS
Neuronal cell and neuronal stem cell differentiation and
culture
To explore if and how m6A methylation molecular processes might
contribute to the spatial and temporal changes proposed in synaptic
tagging and capture mechanisms, we chose to examine the relationships
between m6A effector machinery and modified RNAs in synaptic
subdomains during plasticity phases in two cell human neuronal cell
lines. The neuroblastoma cell line SH-SY5Y and cerebellar medulloblastoma
cell line TE671 can be differentiated from a neuroblast-like state into
mature human neuronal cells through the use of different methods e.g. the
addition of retinoic acid and dibutyryl-cyclic-adenosine-monophosphate
(dbcAMP) [25, 26]. When differentiated, cells extend long, branched
processes and demonstrative properties of neuron subtypes such as
cholinergic and glutamatergic neurons [27]. We chose to examine both
differentiated cell lines to demonstrate robustness in findings. TE671 and
SH-SY5Y cells were cultured under standard conditions and in complete
Dulbecco’s Modified Eagle Medium (DMEM) and complete DMEM/F12 (1:1)
Nutrient Mixture Medium, respectively. Cells were maintained at a passage
number under ten and allowed to grow until ~90% confluency. TE671 cells
were differentiated in serum-free DMEM and SH-SY5Y cells in Neurobasal
Medium supplemented with 0.5 mM GlutaMAX (Thermo Fisher Scientific),
B-27 supplement (2 ml per 100ml of medium), and 1% Penicillin/
Streptomycin (10,000 U/ml). The differentiator compound, dbcAMP, was
added at a final concentration of 400 µM to TE671 cultures whereas
retinoic acid at a final concentration of 10 μM was added to SH-SY5Y cells.
The human neural progenitor cell line, ReNcell CX, (EMD Millipore/
Merck) is a neural stem cell line derived from the ventral mesencephalic
region of the developing human brain that differentiates into co-cultures
of functional neurons, astrocytes and oligodendrocytes. It has been used as
a model of human neural development and differentiation [28]. The
ReNcell CX cell line was expanded on laminin coated flasks (20 μg/ml,
Sigma-Aldrich) in ReNcell NSC Maintenance Medium containing fresh EGF
(20 ng/ml) and FGFb (20 ng/ml; EMD Millipore). Cultures were incubated at
37 °C in a humidified atmosphere of 5% CO2. ReNcell CX neural progenitor
cells were differentiated into co-culture of neuronal, astrocytes and
oligodendrocytes by replacing the complete ReNcell CX medium with EGF
and FGFb free medium. They were subsequently fixed at three time points,
0, 1 and 14 days. Cell authentication was performed for all three cells lines
examined, e,g, TE671 and SH-SY5Y and ReNcell CX, by microscopy
observations of cellular morphology and growth curve analysis.
Neuronal activation and calcium imaging and
ribopuromycilation assays
To activate NMDA receptors or to depolarise voltage-gated calcium
channels specifically at synapses or throughout neuronal processes,
dTE671 and dSH-SY5Y cells were differentiated and 100 µM NMDA or 30
mM KCl were added to the media. To stop the process after 15 min or 24 h,
the media was removed and the cells were fixed. To confirm the cellular
response to NMDA or KCl, calcium imaging was performed on live
differentiated cultures using a fluorescent calcium indicator Fluo4-AM
(ThermoFisher) diluted in 20% pluronic acid in DMSO (ThermoFisher) and
culture media for a final Fluo4-AM concentration of 100 µM. Cells were
incubated at 37 °C for 45min in the dark, followed by washes in HBSS and
a 30min incubation. Coverslips were loaded on a LSM710 confocal
microscope (Carl Zeiss, Germany) and videos were captured using a
C-Apochromat 40×/1.2 water objective, 488 nm laser excitation and
emission between 495 and 635 nm after compound applications
(Supplementary Information Video S1 and S2).
A ribopuromycilation assay was conducted to examine actively translating
ribosomes and followed a protocol described by David et al. [29]. In brief,
Puromycin (Sigma-Aldrich, P7255), a protein synthesis inhibitor, and Emetine
(Merck Millipore, 324693), a chain elongation inhibitor, were added to a final
concentration of 18.4 µM and 208 µM, in wells or plates respectively. Cells
were incubated at 37°C (5% CO2) for 5min and washed. Cells were
immediately fixed using 4% Paraformaldehyde and permeabilised for 15min
using labelling buffer (0.05% saponin, 10mm glycine, 5% foetal bovine
serum In 1×PBS), and immunolabelling was performed using an anti-
Puromycin antibody. All NMDA/KCL stimulation and ribopuromycilation
experiments were repeated twice in each condition.
Immunocytochemistry
Cells were fixed using 4% Paraformaldehyde and permeabilized with 0.2%
Triton X-100 and incubated with primary antibodies for two hours. After
washing with 1xPBS, cells were incubated with Alexa Fluor-conjugated
secondary antibodies for one hour. Coverslips with immunostained cells
were mounted using Fluoroshield DAPI (Sigma-Aldrich, F6057) medium
and sealed. A full list of primary and secondary antibodies and the
concentrations used are presented below. Several primary antibodies
specific for m6A/m6Am modifications were assessed and included mouse
monoclonal anti-m6A (Merckmillipore, MABE 1006, clone 17-3-4-1), rabbit
monoclonal anti-m6A (Abcam, ab190886), and rabbit anti-m6A New
England Biolabs (NEB E1610S, USA). These antibodies were compared
using confocal microscopy and indicated a 1.00 correlation (Mander’s M1
and M2 coefficients) in immunoreactivity supporting that they bind to the
same entity (Supplementary Fig. S1).
Advanced microscopy
Cells were visualised using both a confocal LSM880 microscope (Carl Zeiss,
Germany) and super resolution Zeiss ELYRA PS.1 microscope (Carl Zeiss,
Germany). Confocal images were captured at a 12-bit depth and with
consistent settings between samples using a 63× Plan-Apo oil objective
(NA= 1.4). The green channel was excited at 488 nm and emission
recorded at 520 nm. The red channel was excited at 561 nm and emission
recorded at 605 nm. The far red channel was excited at 633 nm and
emission recorded at 670 nm. All channels had an emission recording
bandwidth of 40 nm. Z-stacks were collected at a spacing of 1 µm. At least
20 images per condition were recorded from two cover slips and on two
separate days, generating approximately ~800 activation and ~100
ribopuromycilation confocal images. Negative controls without a primary
antibody were captured for each condition.
For super resolution microscopy, cells were differentiated on square
high-precision 22 × 22mm coverslips (Zeiss, 474030-9020-000) and post-
fixed for 10min in 4% PFA and washed in PBS before mounting using
CFM3 non-hardening medium (CitiFluor, Pennsylvania, CFM3-25). Slides
were kept at room temperature and imaged at 27 °C using a Plan
Apochromat 63×/1.4 oil DIC M27 objective with Zeiss Immersol™ 518F (30 °
C) oil (Zeiss, 444960-0000-000). In a stack scan mode, two tracks were
setup for lasers 488 nm and 561 nm at 25% power and with 100ms
exposure times. SRM SIM grating periods were 28.0 µm and 34.0 µm for
green and red tracks, respectively. Bandpass (BP) filters used were
BP420–480 + BP 495–550 + LP 650 for green and BP 420–480 + BP
570–640 + LP 740 for red. Multiple Z-stacks were captured for all
experiments. Channel shift correction was performed using both 100 nm
TetraSpeck Microspheres (ThermoFisher Scientific, T7279) and marker-
based alignment in Zen Black 2012 software (Carl Zeiss, Germany).
Quantification of colocalization in SRM SIM images was not performed
owing to rapid bleaching of the fluorescent antibodies. Colocalization
analysis and 3D modelling and movies were generated using the Zen Black
colocalisation and 3D modules. At least ten images were captured per
condition for each repeat in the NMDA and KCL activation and
ribopuromycilation experiments generating approximately ~800 activation
and ~100 ribopuromycilation confocal images.















Quantitative localisation at synapses was performed on confocal images
using Fiji software and an in-house methodology which followed standard
imaging analysis principles outlined in [30]. A three channel approach was
used to select synapse-specific regions. The third channel, the synaptic
marker, was manually thresholded to eliminate background and converted
to an 8-bit mask image to create regions of interest. Using the Coloc2 built-
in colocalisation analysis tool, images were autothresholded and
colocalisation between the remaining two channels was evaluated at the
synaptic regions of interest. For presentation purposes, a gamma
correction of 0.45 was applied to the selected representative images. All
experiments were repeated twice and at least five images were captured in
each condition. Pearson’s Correlation Coefficients were calculated using,
and statistical analysis performed in, GraphPad Prism. A two-way ANOVA
(two sided) was performed to compare the interaction and difference in
colocalisation of m6A and related proteins at post-synaptic regions in
activated cells by the two compounds and over two time points (15min
and 24 h). An unpaired t test was performed to compare differences in
colocalisation after activation at active ribosomes and m6A-binding
proteins at synaptic areas. A one-way ANOVA (two sided) was performed
to compare differences in m6A abundance in stem cells differentiating over
time. Statistical significance was considered at p < 0.05.
Scanning transmission electron microscopy (STEM)
Mouse (C57/BL6 strain) hippocampal tissue was fixed with 3% PFA/0.1%
Glutaraldehyde in 0.1 M phosphate buffer through perfusion methods and
polymerised in araldite. 200 nm sections were mounted on graphene oxide
grids. Immunolabelling was performed overnight using the anti-m6A
(Abcam, ab190886) or anti-YTHDF1 (Abcam, ab99080) antibodies at 1:25
concentrations. After washing, the grids were incubated with 5 nm gold
nanoparticle-conjugated secondary antibody for 4 h (Sigma-Aldrich, G7277).
Scanning TEM images were obtained on a JEOL 2100F TEM operating at 200
kV, equipped with JEOL bright field and dark field detectors. STEM tilting
involved a tilt series acquisition at five degree steps. Images were acquired
and processed using Gatan Digital Micrograph software and the open
source Fiji software [31]. By use of the diffuse, high angle annular diffracted
electrons in STEM, the contrast mechanism for the subsequent image is
significantly proportional to the atomic number Z ^ 1.6–1.9 per atom,
increasing the contrast between gold and organic molecules [32].
m6A-sequencing
Non-diseased grey matter and white matter tissue from the parahippo-
campal region were obtained from the Children’s Cancer and Leukaemia
Group (CCLG) through the Nottingham Children’s Brain Tumour Research
Centre. Consent and ethical approval was obtained by CCLG (Ethics
Committee approval, 06/MRE04/86). Foetal brain RNA post conception
weeks (PCW) 22–30 was acquired from clontech #636526. 40–50mg of
snap frozen tissue was used for RNA extraction using the mirVanaTM
miRNA Isolation kit (Applied Biosystems, Carlsbad, CA, USA). RNA was
treated with DNase (Promega, 2 U). Total RNA was measured using Qubit
RNA BR assay kit (Life technologies, Q10210). RNA QC was performed using
Agilent Bioanalyser RNA Nano 6000 kit (Agilent biotechnologies, 5067-
1511). 2 µg of Total RNA was used for rRNA depletion using Ribozero gold
rRNA removal kit (Illumina, MRZG12324). Ribo-depleted RNA was
fragmented to 100 bp using NebNext Fragmentation module (NEB,
E6150S). 1/10 volume of fragmented RNA was separated to use as input
control. 5 μg of m6A Ab (abcam, ab151230) was added to 25 μl of protein G
beads (NEB, S1430) in 250 μl of IPP buffer and incubated at 4 °C. Following
incubation, beads were washed and RNA eluted in RLT buffer (Qiagen,
79216) and purified using 20 μl of MyOne Silane Dynabeads (Life
Technologies, 37002D).
First and second strand synthesis was performed using the NEBNext
RNA First strand synthesis module (NEB, E7525S) and Ultra-Directional RNA
Second Strand Synthesis Module (NEB, E7550S) respectively. Sequencing
libraries from double stranded cDNA were generated using NEBNext® Ultra
II DNA Library Prep Kit for Illumina (NEB, E7645S) according to
manufacturer’s instructions. Library QC was performed using bioanalyser
HS kit (Agilent biotechnologies, 5067-4626). Libraries were quantified using
qPCR (Kapa Biosystems, KK4824) and sequenced according to manufac-
turer’s instructions using Illumina NextSeq500 platform to generate
~40–50 million 75 bp PE reads per sample (Illumina, FC-404-2002).
Preprocessing of reads was performed by FASTQC (version 0.11.5). Adaptor
sequences were removed and trimming was performed with Scythe/Sickle
toolkits. Reads were aligned to the human genome (build GRCh37/hg19)
using HISAT2 (version 2.0.5) [33] with default settings. Stringtie (version 1.3.3)
[34] was used to calculate read coverage, Fragments Per Kilobase Million, and
Transcripts Per Kilobase Million from uniquely mapped reads. N6-
methyladenosine peaks were identified using the exomePeak calling
algorithm [35] using default settings and with the input library as background.
Modified transcripts and regions were annotated to eight non-
overlapping transcript segments using HOMER (Salk Institute, USA)
[36, 37]. These segments were: intron, exon, transcription termination site
(TTS ± 100 bp from stop site), transcription start site (TSS ± 100 bp from
start site), 3′ UTR, 5′ UTR, non-coding, and intergenic. m6A motifs were
identified using DREME [38]. Transcripts were examined for multi-
modification (N > 3), i.e. the number of district m6A peaks detected, and
included only distinct m6A peaks with distances larger than 400 bps along
the transcript. Functional gene ontology annotation was performed using
DAVID’s Functional Annotation Clustering [39] and assessed all modified
transcripts as well as sub groups of transcripts with modifications identified
at specific regions, e.g. 3′ UTR, 5′ UTR, non-coding, and intergenic.
Antibodies
The following primary antibodies and dilutions were used: mouse anti-m6A
(Merck Millipore, MABE 1006, clone 17-3-4-1) 1:250, mouse anti-YTHDF3
(Santa Cruz Biotech, sc-377119) 1:100, and mouse anti-Puromycin (Merck
Millipore, MABE343) at 1:10000, rabbit anti-Dcp1a (Abcam, ab47811) 1:250,
rabbit anti-m6A (Abcam, ab190886) 1:250, rabbit anti-VGluT1 (Abcam,
ab72311) 1:500, rabbit anti-DLG4 (Sigma-Aldrich, HPA010122) 1:250, rabbit
anti-YTHDF1 (Abcam, ab99080) 1:100, rabbit anti-ALKBH5 (Merck Millipore,
ABE1013) 1:100, rabbit anti-L7A (Cell Signalling Technology, R225) 1:250,
rabbit anti-FMR1 (Sigma-Aldrich, HPA050118) 1:250, goat anti-VGluT1
(Abcam, ab110139) 1:100, and goat anti-PSD95 (Abcam, ab12093) 1:100.
The secondary antibodies were donkey anti-mouse AF488 (Abcam,
ab150105) 1:500, goat anti-rabbit AF568 (Abcam, ab175471) 1:500, and
donkey anti-goat AF647 (Sigma-Aldrich, SAB4600175).
RESULTS AND DISCUSSION
Advanced microscopy spatial mapping of m6A complexes at
synapses
Using antibodies specific for m6A modification, we used confocal
microscopy to characterise m6A abundance and distribution in
two differentiated human neuronal cell lines (dSH-SY5Y and
dTE671). We observed m6A modified transcripts throughout all
cytoplasmic regions, including axons and dendrites, but an m6A
signal was absent from the nucleus. Double labelling of m6A and
VGluT1, a marker of presynaptic terminals, and PSD-95/DLG4, a
marker of postsynaptic sites, provided evidence of co-localisation
(Supplementary information file, Fig. S2), indicating that m6A
tagged RNAs are at both the pre- and post- synaptic terminals.
To examine m6A modified transcripts within the cytoplasm and
at synaptic sites at a higher resolution (i.e. 80–120 nm), we
visualised cells using super-resolution Structured Illumination
Microscopy (SIM). We observed m6A modified transcripts within 1
µm of VGluT1 or DLG4/PSD-95 (Fig. 1 A–B, video). We also observed
a moderate abundance of overlap in fluorescence signals for m6A
modified transcripts and m6A readers, i.e. YTHDF1 (~13%) and
YTHDF3 (~28%), confirming that modified transcripts are in near
proximity to both reader proteins in the cytoplasm (Fig. 1 C and D,
Supplementary information video S3). However, Dcp1a, a marker of
RNA processing bodies (P bodies) and mRNA decay sites, showed
only a few occurrences of overlap with m6A modified transcripts
(Fig. 1E). Similarly, ALKBH5, an eraser protein, was found to be
mostly located in the nucleus (Fig. 1F). However, we observed some
ALKBH5 colocalisation with m6A modified RNA within the
cytoplasm suggesting that in addition to nuclear RNA mechanisms,
e.g. nuclear RNA export, splicing [40, 41], m6A demethylation has a
function in RNA processing outside the nucleus.
Upon image rotation of the SIM 3D images, some instances of
apparent colocalisation between m6A and synaptic markers were
found to have gaps of approximately 120 nm (Supplementary
information file, Fig. S3 A, B). Image rotation also indicated that
the m6A readers YTHDF1, YTHDF3, eraser ALKBH5 as well as the P
body marker Dcp1a, were always adjoining to m6A-modified
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transcripts (Supplementary information file, Fig. S3, C–F). More-
over, Dcp1a was commonly adjacent to two m6A modification
signals suggesting that there is clustering of Dcp1a with modified
transcripts. These results indicated that m6A-mediated regulation
of protein expression is important at pre- and postsynaptic sites,
and that in differentiated but quiescent, i.e. non-synaptically
activated cells, m6A modified RNA is bound to the reader proteins,
YTHDF1 and YTHDF3 more often than to the eraser ALKBH5.
m6A dynamics are plasticity-time dependent and involves
ALKBH5 translocating out of the nucleus
As m6A modified transcripts and m6A-binding reader proteins are
abundant within neuronal processes, we performed triple-
labelling immunofluorescence and confocal microscopy to assess
m6A modified mRNAs and m6A-binding proteins directly at
synapse-specific regions of interest. (Fig. 2A, top row; Supplemen-
tary information file, Fig. S4) in dTE671 and dSH-SY5Y cells. In
differentiated but non-synaptically stimulated cells, we observed
modest colocalisation (Pearson’s Correlation Coefficients [PCC]
values of ~0.20) between m6A modified transcripts and YTHDF1/
YTHDF3/Dcp1a at pre- and post- synaptic ROIs (Fig. 2C–E and
Supplementary information file, S4). In contrast, ALKBH5 displayed
a negative correlation at post synaptic sites (dSH-SY5Y PCC −0.25
SEM 0.02; dTE671 PCC −0.23, SEM 0.02) again suggesting that
during quiescence the eraser protein is not commonly in the
vicinity of modified transcripts (Fig. 2F and Supplementary
information file S4).
We next examined spatial-temporal patterns of m6A-modified
transcripts and m6A effector proteins at synapses after activation
of NMDA receptors or cell membrane depolarisation by voltage-
gated calcium channels. A cellular response to NMDA or KCl was
confirmed by calcium imaging (Supplementary information
videos S1-2). We examined the responses to stimulation at two
different time points, 15 min or 24 h after application, which are
analogous to early E-LTP and late L-LTP phases. We found
significant differences in co-localisation of m6A mRNAs and
m6A-interacting proteins before and after synaptic stimulation at
pre- and post- synaptic regions (Fig. 2 and Supplementary
information file Fig. S4). At postsynaptic sites, colocalisation of
m6A modified transcripts with the readers YTHDF1 and YTHDF3
increased significantly at 15 min after application of NMDA or KCl
in dSH-SY5Y (p < 0.05) and dTE671 (p < 0.005) cells and remained
high at 24 h (Fig. 2C, D, Supplementary information file S5)
indicating the involvement of both these m6A reader proteins in
regulating local RNA processing during postsynaptic plasticity
processes. Conversely, Dcp1a, a marker of RNA decay sites, was
significantly increased (p < 0.05) only at 24 h after NMDA or KCl
application (Fig. 2E) suggesting that some modified transcripts are
degraded during a late phase of LTP.
In contrast to a non-stimulated state, when the ALKBH5 eraser
protein showed a negative correlation with m6A abundance, 15
min following NMDA application there was a significant increase
(p < 0.00005) in ALKBH5 abundance and m6A modified mRNA
colocalisation at postsynaptic sites (dSH-SY5Y PCC 0.17 SEM 0.05;
dTE671 PCC 0.17, SEM 0.02) (Fig. 2F). This suggests that the eraser
protein is transported from the nucleus out to cytoplasmic
synaptic sites during early plasticity as evident in Fig. 2A. At
presynaptic sites, colocalisation of m6A modified RNAs with
YTHDF3 and ALKBH5 was also significantly increased at 15 min
after NMDA or KCl stimulation (p < 0.005) but only YTHDF3
remained increased at 24 h in dTE671 cells, p < 0.05 (Supplemen-
tary information file, Fig. S5). Together, these results demonstrate
that the reader effector proteins are involved in RNA regulation
during both short term and longer term plasticity phases at both
pre- and post- synaptic sites after NMDA activation and that
‘demethylation’ by the ALKBH5 eraser protein is part of the
mechanism following short term synaptic plasticity.
The Fragile X Mental Retardation Protein (FMR1/FMRP), which
causes the neurodevelopmental delay disorder fragile X syn-
drome, is reported to transport transcripts to post-synaptic sites
following NMDA receptor activation and to repress translation by
stalling mRNA-linked ribosomes [42, 43]. To gain insight into the
involvement of FMRP in m6A mechanisms, we assessed whether
FMRP is in close vicinity to m6A modified RNAs at synapses, and
whether stimulating with NMDA or KCl changes this relationship.
We found that colocalisation in non-stimulated cells was modest
(PCC of 0.25) at postsynaptic sites. After activation with NMDA,
Fig. 1 Spatial mapping of m6A-modified transcripts and
m6A-binding proteins at synapses. Super resolution structured
illumination 3D microscopy of differentiated human neuronal cells
shows colocalisation of m6A modified transcripts (green) with
A presynaptic VGluT1 (red), B post synaptic PSD-95/DLG4 (red),
C YTHDF1 reader (red), D YTHDF3 reader (red), E Dcp1a (red),
F ALKBH5 eraser (red). Left column, maximum intensity projections
SIM images of the widefield grey scale inset image (yellow box).
Middle column, 3D models of zoomed in regions of interest (white
squares in the left column). Right column, resolution at which two
fluorescent puncta can be discerned (range 80–120 nm).
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FMRP colocalisation with m6A-methylated transcripts at postsy-
naptic sites significantly increased (p < 0.05, dSH-SY5Y; p < 0.005,
dTE671 Fig. 2G). However, applying KCl did not cause a significant
change in FMRP localisation with modified transcripts suggesting
perhaps that a local rise of [Ca2+]i near synapses is needed for the
association of FMRP. These results provide evidence that FMRP is
involved in m6A-regulatory mechanisms influencing short term
plasticity at glutamatergic synapses.
Demethylation at local active ribosomes
Given that the increased abundance of m6A-modified transcripts
colocalised with reader and eraser proteins after short term
glutamatergic activation, we sought to confirm that this process
was occurring at actively translating ribosomes local to synapses.
Using protein synthesis inhibitors and a ribopuromycilation
immunofluorescence assay, we stalled translation in dTE671 cells
before and 15min after NMDA receptor activation and quantified
actively translating ribosomes with m6A modified RNAs and
YTHDF1, YTHDF3 and ALKBH5 at post-synaptic synapses. We
found that there was no difference between the quiescent and
stimulated state in the amount of fluorescence at active ribosomes
throughout the whole cell [unpaired t test, p= 0.48] (Supplemen-
tary information Fig. S6). Furthermore, although Dcp1a was found
abundant at synapses before synaptic stimulation, the Dcp1a
protein showed low colocalization with translating ribosomes, and
after exposure to NMDA co-localisation was further reduced (PCC
Fig. 2 m6A regulation at synapses is activity-time dependent and involves m6A demethylation. RNA binding proteins change in proximity
to modified transcripts after synaptic stimulation as imaged by confocal microscopy. A 15min after NMDA activation of dSH-SY5Y cells
induces increased colocalisation between m6A-RNAs (green), the eraser protein ALKBH5 (red) and post synaptic marker, PSD-95 (magenta).
Insets of selected regions are shown on the right. B Experimental design. Mean Pearson’s Correlation Coefficient for m6A colocalisation with
YTHDF1 (C), YTHDF3 (D), Dcp1A (E), ALKBH5 (F) and FMRP (G) at postsynaptic sites at 15min or 24 h after NMDA and KCl application in dSH-
SY5Y cells. Error bars denote 95% CI. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005, ****p ≤ 0.00005.
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−0.157, p < 0.005) (Fig. 3E). These data are consistent with a lack of
mRNA degradation during local synaptic protein synthesis.
In contrast, there was a significant increase in m6A modified
transcripts (p < 0.0005) (Fig. 3B) and increased abundance of
YTHDF1 (p < 0.0005) and ALKBH5 (p < 0.005) after synaptic
activation at active ribosomes at postsynaptic sites (Fig. 3A, C, D,
Supplementary information Fig. S7). These findings strongly
suggest that during the early phase of NMDA mediated plasticity
in post synaptic compartments, the RNA reader proteins along
with modified transcripts are involved in RNA translation. The
significant increase in colocalisation of ALKBH5 with actively
translating polyribosomes, also provides evidence for a role of
demethylation in local protein synthesis during early plasticity.
However, the mechanistic consequences of de-modification and
involvement in translational processing, i.e. during the different
stages of translation, the timing and the targeting of specific
modified populations, still remain to be determined and
confirmed.
m6A-RNAs increased abundance with synaptic maturation
m6A methylation has previously been associated with proliferation
and differentiation in embryonic stem cells [44–46] and post-natal
Fig. 3 m6A-modified RNAs increase at actively translating synaptic ribosomes 15min after synaptic activation. A Confocal microscopy
indicates non-activated and NMDA activated dTE671 cells show regions of colocalisation between m6A-modified RNA (red) at post synaptic
sites (PSD-95, magenta) and translationally active ribosomes indicated by puromycin binding (green). Mean Pearson’s Correlation Coefficient
calculated for colocalisation between actively translating ribosomes 15min after activation and (B) m6A modified transcripts (C) YTHDF1
reader, (D), ALKBH5 eraser (E) and Dcp1a in postsynaptic areas. Error bars denote 95% CI. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005.
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development of the mammalian cerebellum [47]. However, the
role of specific YTH reader proteins during synaptogenesis is not
known. We investigated the abundance of m6A modified
transcripts and proximity with effector proteins at synapses
during differentiation of human neuronal progenitor stem cells
(hNPSCs) into co-cultures of neurons, astrocytes and oligoden-
drocytes. Three time points were assessed: before differentiation;
one day after differentiation (early differentiated); and 14 days
after differentiation (fully differentiated) – a time point which
reflects late stage synaptic maturation [48]. m6A modified
transcripts were found to be very low throughout the cytoplasm
in undifferentiated and early differentiated cells (Fig. 4A). How-
ever, in fully differentiated cells, m6A-modified RNAs increased
dramatically. Quantifying colocalisation of modified transcripts
Fig. 4 m6A modified RNAs increase, and colocalization with YTHDF3 decreases, at synapses during synaptic maturation. A Human neural
progenitor cells examined by confocal microscopy show m6A-modified RNAs (green) increase in abundance during synaptic maturation
(1 and 14 days differentiation) and increase in co-localisation at postsynaptic sites (magenta) with YTHDF1 (red) and Dcp1a (red) but decreases
with YTHDF3 (red). Arrows point to regions where there is high white fluorescence signal indicating high colonisation of modified RNA and
effector/dcp1a proteins at synapses. Far right, Pearson’s Correlation Coefficients for colocalisation between m6A modified transcripts, m6A
reader binding proteins, YTHDF1, YTHDF3 and Dcp1a, over the three time points. B High magnification images showing less co-localisation
between YTHDF3 (red) and m6A modified RNAs (green) at postsynaptic regions (PSD-95, magenta) encircled in white at day 14. Error bars
denote 95% CI. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005.
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with YTH readers and the Dcp1a protein at postsynaptic sites
demonstrated a significant increase in colocalisation between
m6A-modified RNAs and YTHDF1 (p < 0.0005) as well as with
Dcp1a (p < 0.0001) at 14 days, but a significant decrease in
colocalisation between m6A and YTHDF3 (p < 0.005) in fully
differentiated cells (Fig. 4A). Indeed, although at 14 days we
observed abundant modified RNAs at synapses, YTHDF3 appeared
more dispersed within the cytoplasm and appeared excluded at
postsynaptic sites (Fig. 4B). These findings suggest that the
influence of m6A regulation on synaptic differentiation processes
involves both YTHDF1 at YTHDF3 effector proteins at early stages
but more prominently YTHDF1 at the later stage of synaptic
maturation.
To explore whether the difference in the readers’ protein
localisation during synapse formation related to changes in gene
expression during development, we examined RNA-seq data for
16 brain regions over post conception weeks (pcw) 4–37 and post
birth years 0–40 generated by the BrainSpan Atlas of the
Developing Human Brain [45]. We observed that YTHDF1 and
YTHDF3 show clear differences in time and brain tissue specific
expression patterns, and in particular, during the periods critical
for synapse formation and synaptic pruning (pcw 20–37)
(Supplementary Information Fig. 8). In contrast, and although
the eraser ALKBH5 has an overall higher abundance than YTHDF1,
AlKBH5 and YTHDF1 show similar spatio-temporal patterns of
expression including the synapse formation period and up to mid
adulthood. These data suggest that the role of these effector
proteins upon protein synthesis at synapses during the process of
synaptic maturation, may be driven in part by a coordinated
pattern of differential gene expression and abundance of YTHDF1
and YTHDF3.
One proposed explanation for such a switch in gene expression
and co-localisation at synapses involves regulation by the
antisense YTHDF3-AS1 Lnc RNA which is located adjacent to the
YTFDH3 gene locus. YTHDF3-AS1 transcripts are reported to
interact with proteins involved in RNA processing including
YTHDF2 [49, 50]; with proteins involved in hnRNP complexes
[51]; and with RNA-binding proteins involved in cytoplasmic
transport [52]. Furthermore, from m6A-sequencing data we
observed that YTHDF3-AS1, as well as all m6A effector protein
transcripts (Fig. 6 E), are themselves m6A modified in brain tissue.
Thus, it may be that YTHDF1 and YTHDF3 abundance at
subcellular locations is controlled by feedback systems involving
m6A autoregulation of effector proteins, the YTHDF3-AS1 transcript
and proteins which influence RNA processing, packaging and
transport. Future studies which aim to explore m6A effector
proteins and RNA-protein interaction networks using targeted
functional experimental designs, i,e genotype specific mutants or
CRISPR-cas assays, would provide further insight into differential
colocalization and expression.
In situ CA3 synaptic mapping of m6A-RNAs
To examine the spatial locality of modified transcripts at the nano
resolution within single mature synapses in situ, we performed
scanning transmission electron microscopy imaging on primary
mouse tissue from the Cornu Ammonis regions of the hippocam-
pus. In CA3/CA4 regions, we observed modified transcripts near to
presynaptic terminals and at postsynaptic densities (Fig. 5A, B) as
Fig. 5 Modified RNAs are present in situ at pre- and post- synaptic sites within CA3/CA4 neurons. A, B STEM imaging indicates m6A
modified RNAs at both at the postsynaptic compartment (coloured blue and shown by the yellow arrow), presynaptic terminals (coloured
green) and in processes (orange). C, D YTHDF1 was found clustered within the presynaptic region (green) whilst in the postsynaptic sites
(blue) the protein is more distributed and located at both postsynaptic terminals near to the active zone as well as throughout the bouton.
YTHDF1 was also abundant within dendritic spines (pink). The structure evident on the left hand side of A and B is the amorphous carbon
support film.
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well as in cytoplasmic processes. In addition, the YTHDF1 reader
was found to be present in clusters at presynaptic sites, but had a
more dispersed distribution at the postsynaptic sites including at
postsynaptic terminals (Fig. 5C, D), and had a wider distribution
within dendritic spines (pink region in Fig. 5D). These observations
provide further evidence that m6A regulatory mechanisms maybe
important for both pre- and post- synaptic processing within
critical pathways such as the perforant pathway in the
hippocampus.
m6A methylome in the human parahippocampus
The parahippocampus is composed of white matter tissue,
predominately comprised of myelinated axons and glia cells such
as oligodendrocytes; and grey matter, composed of cell bodies,
dendrites and synapses. Although traditionally the focus of
plasticity research has been on grey matter neuronal and synaptic
sites, the importance of white matter myelination in plasticity
mechanisms such as memory consolidation, has gained promi-
nence [53–55]. To assess m6A methylation patterns across the
length of individual transcripts and to characterise modified
transcripts belonging to function categories within the parahip-
pocampus, we performed high throughput m6A-seq of human
parahippocampal grey and white matter tissue. In addition, we
sequenced foetal brain tissue post conception weeks 20–33, a late
development stage in which populations of neuronal and glial
cells, and functional synapses, exist, to compare characteristics
Fig. 6 m6A methylome in human parahippocampus grey and white matter. Topological distribution of m6A sites along transcripts and
number of m6A peaks and modified transcripts in A grey matter, B white matter and C foetal brain. D Number of m6A modification sites per
transcript. E m6A reader, writer and eraser protein transcripts and F synapse related protein transcripts show multi-modification. G Gene
ontology processes and disease terms enriched for m6A modified transcripts presented by most significant P values and largest fold
enrichment in grey and white matter tissue.
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with the adult white and grey matter hippocampal methylome.
We identified 9,579 high confidence peaks in 5298 coding
transcripts in grey matter tissue; 14,064 peaks in 6968 coding
transcripts in white matter tissue and 14,249 peaks in 6730 coding
transcripts in foetal brain (Fig. 6 A–C). We also identified 851, 1460
and 1262 non-coding mRNAs in grey matter, white matter, foetal
brain tissue, respectively. The most enriched m6A binding motif
was found to be GGAC, consistent with the previously reported
RRACH motif [56].
We found m6A methylation occurred predominantly within
exons (~45%) and the 3′UTR (~30%) and this did not vary between
tissues (Fig. 6 A–C). The mean number of methylation peaks/sites
per transcript was approximately two, with a 50–25–25 percent
divide in transcripts with one, two or three or more distinct m6A
modified regions (Fig. 6D). Transcripts encoding the majority of
known m6A writer, reader and eraser and other binding proteins
were themselves modified, providing evidence for m6A auto-
regulation (Fig. 6E). We observed that the eraser, writer and FMRP
protein transcripts had on average only one modified region per
transcript. In contrast, m6A readers were found to have a higher
number of average modification sites per transcript (average 2.7),
especially YTHDF2 with ~4.7 sites per transcript. Moreover, all four
multi-modified YTH transcripts had modification sites within exons
or the 3′UTR, suggesting that they are m6A modified rather than
modified at the cap-adjacent N6,2′‐O‐dimethyladenosine (m6Am)
site [57].
One class of cell surface protein, protocadherins, were
commonly found to have a high number of modification sites,
exhibiting an average of 4.5, and range of 0–28, modification sites
per transcript (Supplementary information Table S1). These
proteins mediate trans-synaptic interactions and cell to cell
communication and have a suggested role in the generation of
specific synaptic connections [58]. In addition, classes of proteins
which are traditionally associated with synaptic structure and
function were also characterised as multi-modified (Fig. 6F). For
example, CAMK2B, involved in synaptic spine formation and a
classic marker of LTP, had 4.0 modification sites in all tissue types
and all glutamate NMDA receptor subunits were found to be
modified (Supplementary information Fig. S9). Taken together,
these results indicate that: m6A binding proteins undergo m6A
autoregulation; protocadherins transcripts are highly multi-
modified; and multi-modification by m6A commonly occurs on
structural and activity-related synaptic transcripts.
Gene ontology annotation of modified transcripts revealed
functional processes most significantly enriched in grey matter
related to neuronal and synaptic functions, as well as protein
binding, cell junctions and cell adhesion, and post-translational
modifications, e.g. phosphorylation and ubiquitination (Fig. 6G, SI
Tables S2, S3). White matter tissue indicated different processes
were regulated by m6A modification. For example, zinc finger
protein domains, and processes associated with the nucleus and
transcription regulation or myelination and axons (Fig. 6G, SI
Table S4, S5). Consistent with previous reports for early developing
foetal cortical tissue [59], late-stage foetal brain showed enrich-
ment for transcripts which are associated with nervous system
development (SI Table S6). Only one third of significantly enriched
process terms were shared across all tissues indicating high
variability in which transcripts are modified.
We next examined whether the m6A topology along mRNA
transcripts revealed enrichment for specific biological processes
(SI Tables S8–S12). We found transcripts that were methylated in
the 5′ region were enriched for functions relating to neuronal
processes and synaptic membranes. Exon-methylated transcripts
in grey matter were enriched more for cell-adhesion proteins and
cell membranes, whereas in white matter for transcriptional
related processes. Transcripts methylated in the 3′ region showed
the most functional diversity spanning cellular housekeeping
functions such as Golgi membrane function and lipid proteins for
grey matter and mitochondria function for white matter. These
results together suggest that where a transcript is modified
regulates specific processes and pathways which may have
consequences for both translational processing and physiological
function.
Finally, in grey and white matter tissue, modification of
transcripts belonging to the disease classification terms, ‘psychia-
tric disease’ (p > 5*10−13, GM; p > 1.7 *10−08, WM) and ‘neurolo-
gical disease’ (p > 1.5 *10−6, GM, p > 4.5 *10−5, WM) (Fig. 6G,) were
enriched. For example, schizophrenia, the most significantly
enriched disease in all tissue types, had over 250 different
schizophrenia-related transcripts methylated in grey matter (p=
6.1*10−9), white matter (p= 2.5*10−4) and foetal brain (p=
1.4*10−4). Furthermore, transcripts associated with other health
conditions such as substance abuse disorders and weight gain
were highlighted as m6A enriched (SI Table S13). This provides
evidence that m6A regulation of specific protein pathways could
be a significant factor contributing to the expression of brain
disorders.
DISCUSSION
Nucleotide modification as a means to modulate plasticity
processes has long been hypothesised [60, 61]. Here we presented
new insight into m6A methylation processes as a fine-tuning
mechanism of translation at pre- and post- synaptic sites and
which we propose is an intrinsic component of synaptic tagging
and capture. We provided evidence that demethylation by
ALKBH5 is an active process during short term plasticity and is
involved in active translation at ribosomes local to post-synaptic
sites. We also showed that the involvement of effector proteins,
YTHDF1, YTHDF3 and ALKBH5 differ between short- and long-term
plasticity phases and at synapses during synaptic maturation. As
m6A binding proteins are currently being assessed as pharmaco-
logical targets [62], the temporal changes of these effector
proteins need to be considered for drug developments targeting
cognitive disorders.
Modification of RNA by N6-methyladenosine is known to
influence the cellular fate of mRNA through nuclear processing,
transcription/translation initiation, and mRNA transport by RNA
binding proteins [63–65]. Cell type, availability of m6A effector
machinery, and m6A-RNAs subcellular spatial localisation are
factors likely to determine what biological processes are
regulated, where and when. In neurons, modified RNAs are
transported from the nucleus to cytoplasmic sites in RNA granules
for RNA processing, such as translation repression in P-bodies, or
RNA translation at synaptic ribosomes. We propose that demethy-
lation during early plasticity at actively translating synaptic
ribosomes, as indicated by our findings, is intrinsic to early tag
setting and hence early LTP,- a stage which is postulated to be
transcription independent. However, mechanisms which may
disrupt RNAs being transported to specific spatial locations such
as synaptic compartments, may affect, ‘new’ transcription-
dependent, later stages of plasticity (L-LTP). Indeed, depletion of
the writer Mettl3, reader YTHDC1 and eraser ALKBH5 effector
proteins, are reported to cause deficits in nuclear export pathways
as well as alterations in the abundance of modified and
unmodified mRNAs within the nucleus and cytoplasmic compart-
ment [41, 66, 67]. If export into the cytoplasm was greatly
decreased, specific RNAs needed for late-stage plasticity to, for
example, sustain a tag over time, or activate tag related pathways,
may not be available. We therefore postulate that the result of
disruption to both local tag setting by demethylation and nuclear
export and transport to already tagged synapses could contribute
to synaptic impairment. Indeed, in support of this notion,
mutations within genes encoding nuclear mRNA export complex
proteins are known to cause forms of syndromic intellectual
disabilities [68, 69].
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Specific classes of mRNAs including the m6A effector proteins
were found to be multi-modified suggesting that both the
autoregulation of the m6A machinery and the spatial locality of
the modification along transcripts provide further temporal
control over the fate of RNAs. Such highly co-ordinated regulation,
may for example, involve m6A-modified YTHDF3-AS1 antisense Lnc
transcripts modifying YTHDF reader abundance at synapses
during critical stages of development including during synaptic
maturation. In addition, as indicated from the m6A-seq data, these
regulated processes are likely to be influenced by, and to act
upon, posttranslational modification pathways, e.g. protein
phosphorylation, thereby controlling cascades of orchestrated
events fundamental to plasticity [70]. The difference between grey
and white matter tissue methylome profiles further demonstrate
that the cellular context and local environment are fundamental
factors dictating m6A regulated pathways. With the emerging
evidence of white matter myelination plasticity, i.e. activity-
dependent formation of myelin contributing to memory con-
solidation [54, 55], it will be important to determine what factors
within myelinating glia environments govern m6A-RNA regulatory
processes. Future m6A/m mRNA studies of cell populations using
techniques such as miCLiP-seq [71] to map sites at base resolution,
or nanopore technologies [72] to potentially quantify the number
of modifications per base, will be valuable in deciphering cell
population specific characteristics.
The YTHDF proteins have recently been shown to promote
liquid–liquid phase separation and the formation of highly
condensed membraneless macromolecular aggregates such as stress
granules, P bodies or ribonucleoprotein granules [12, 73, 74]. One
recent model proposed [12, 73], suggests that m6A multi-modified
mRNAs (also termed polymethylated mRNAs) act as a multivalent
scaffold for the binding of YTHDF proteins which enhances phase
separation into intracellular phase-separated compartments. Given
that post synaptic densities (PSDs) and presynaptic active zone
regions are recognised to be dynamic molecular assemblies [75, 76]
and that evidence suggests that there are nanodomain assemblies
such as excitatory synapse PSDs condensates which are distinct from,
and do not mix with, inhibitory synapse PSDs condensates [75], we
hypothesise that contingent upon the local availability of the YTHDF
proteins, and during early phase synaptic plasticity, multi-modified
RNA–YTHDF interaction contributes to formation of dynamic PSD
and presynaptic nanodomains.
Observations from our study support such a hypothesis;—
namely, shortly after synaptic activation we observed an increase
of the YTHDF proteins and the ALKBH5 eraser with m6A-RNAs at
post synaptic sites. Furthermore, multi-modified mRNAs in grey
matter tissue were found to be mRNAs encoding proteins
involved with PSD synaptic function. The role for the ALKBH5
eraser protein in a putative phase separation process may be to
govern the number, or distribution, of m6A methylated sites along
local mRNAs and hence influence the stability of YTHDF protein
interactions. Alternatively, upon synaptic activation, demethyla-
tion by ALKBH5 may initiate rapid local protein translation
resulting in an increase in local protein concentrations necessary
for phase separation to occur. As a consequence, and as
previously suggested [75, 77], mutations within single synaptic
proteins could modulate, at a network level, synaptic condensed
nanodomain assemblies and hence impair synaptic transmission.
Examining the involvement of known mutated genes for
neurodevelopmental disorders in m6A RNA methylation mediated
sub-domain assemblies or disassembly of concentrates, e.g. with
YTHDF proteins at ePSDs, may provide valuable insight into basic
nanophysiology as well as uncover novel protective ‘plasticity’
mechanisms underlying synaptic function.
Our observations that transcripts for cell adhesion proteins such
as cadherins which mediate trans-synaptic interactions and cell to
cell communication are highly modified, also suggest a role for
m6A RNA methylation in cell to cell signalling between neurons
and between neuronal and non-neuronal cells. Indeed, the
transport of modified RNAs between cells may be an additional
means by which information is transferred. Such communication
processes would have implications for disease and could be a
seeding mechanism by which pathology spreads between brain
regions in neurodegenerative disorders. How such m6A regulated
processes contribute to disease pathologies or brain states, such
as addiction disorders, that have the potential to be reversed, will
provide valuable insight from which new therapies can emerge.
However, with growing evidence of significant divergence in
plasticity-related protein gene expression between species [78],
epitranscriptomic profiling using human brain will be critical for
the translation of findings into clinical use.
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